Home/Filings/4/0001415889-25-002818
4//SEC Filing

Jones Christy 4

Accession 0001415889-25-002818

CIK 0001674632other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 8:30 PM ET

Size

10.3 KB

Accession

0001415889-25-002818

Insider Transaction Report

Form 4
Period: 2025-01-31
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-01-31+48,73048,730 total
    Exercise: $7.51Exp: 2032-07-26Common Stock (48,730 underlying)
  • Award

    Director Stock Option (right to buy)

    2025-01-31+9,1379,137 total
    Exercise: $7.51Exp: 2031-12-07Common Stock (9,137 underlying)
  • Award

    Director Stock Option (right to buy)

    2025-01-31+9,1379,137 total
    Exercise: $7.51Exp: 2031-12-07Common Stock (9,137 underlying)
Footnotes (4)
  • [F1]The shares subject to this option shall vest in 36 equal monthly installments measured from April 27, 2021.
  • [F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
  • [F3]The shares subject to this option shall vest in 36 equal monthly installments measured from July 20, 2021.
  • [F4]The shares subject to this option shall vest in 48 equal monthly installments measured from July 27, 2022.

Issuer

Beta Bionics, Inc.

CIK 0001674632

Entity typeother

Related Parties

1
  • filerCIK 0002048467

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 8:30 PM ET
Size
10.3 KB